5-alpha Reductase Inhibitor [EPC]

5-alpha Reductase Inhibitor [EPC] was reported 102491 times

Drugs of the 5-alpha Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 279 0.9824
1 RIGHT ATRIAL HYPERTROPHY 91 0.8273
2 HAIR TRANSPLANT 51 0.7612
3 SEMEN VISCOSITY DECREASED 66 0.7174
4 ORGANIC ERECTILE DYSFUNCTION 249 0.5831
5 SEMEN ANALYSIS ABNORMAL 107 0.5573
6 TESTICULAR FAILURE 75 0.5474
7 MALE GENITAL ATROPHY 58 0.5421
8 GENITAL ATROPHY 81 0.5294
9 SEMEN VOLUME DECREASED 516 0.5145
10 SPIROMETRY ABNORMAL 303 0.5067
11 MITE ALLERGY 306 0.4672
12 PENILE SIZE REDUCED 412 0.4332
13 PAINFUL EJACULATION 95 0.4204
14 HYPOGONADISM MALE 87 0.3750
15 VARICOCELE 97 0.3674
16 MYCOTIC ALLERGY 304 0.3556
17 DUST ALLERGY 305 0.3109
18 PENILE CURVATURE 73 0.3106
19 HYPOGONADISM 314 0.3106
20 PULMONARY VASCULITIS 167 0.3104
21 TOTAL LUNG CAPACITY ABNORMAL 119 0.3059
22 GENITAL DISORDER MALE 65 0.3052
23 PENIS INJURY 106 0.2944
24 SPERM CONCENTRATION DECREASED 100 0.2890
25 CAPILLARITIS 79 0.2862
26 TESTICULAR ATROPHY 245 0.2810
27 GENITAL HYPOAESTHESIA 281 0.2752
28 EJACULATION FAILURE 551 0.2744
29 EJACULATION DISORDER 734 0.2585
30 ORGASMIC SENSATION DECREASED 97 0.2566
31 MALE ORGASMIC DISORDER 129 0.2476
32 TESTICULAR PAIN 755 0.2379
33 DANDRUFF 510 0.2304
34 ANDROGEN DEFICIENCY 78 0.2222
35 APPLICATION SITE DRYNESS 754 0.2219
36 CONJUNCTIVITIS ALLERGIC 328 0.2213
37 APPLICATION SITE ACNE 106 0.2163
38 SEXUAL DYSFUNCTION 2515 0.2143
39 AMAUROSIS FUGAX 230 0.2136
40 PROSTATIC PAIN 87 0.2132
41 GENITAL PARAESTHESIA 61 0.2103
42 SPERMATOZOA ABNORMAL 53 0.2015
43 LOSS OF LIBIDO 1786 0.1984
44 APPLICATION SITE ULCER 136 0.1921
45 MALE SEXUAL DYSFUNCTION 107 0.1786
46 INFERTILITY MALE 80 0.1770
47 ERECTILE DYSFUNCTION 4537 0.1765
48 ORGASM ABNORMAL 131 0.1619
49 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 117 0.1596
50 TESTICULAR DISORDER 160 0.1589
51 HYPERTRICHOSIS 293 0.1580
52 APPLICATION SITE PAPULES 160 0.1508
53 PENIS DISORDER 358 0.1445
54 PREMATURE EJACULATION 93 0.1442
55 APPLICATION SITE EXFOLIATION 552 0.1339
56 ADVERSE DRUG REACTION 11423 0.1271
57 REPRODUCTIVE TRACT DISORDER 50 0.1238
58 BRONCHIAL WALL THICKENING 88 0.1224
59 TRANSMISSION OF DRUG VIA SEMEN 56 0.1162
60 APPLICATION SITE PRURITUS 2625 0.1156
61 NEURITIS 175 0.1133
62 LIBIDO DISORDER 140 0.1076
63 NORMOCHROMIC NORMOCYTIC ANAEMIA 317 0.1054
64 HAEMATOSPERMIA 73 0.1053
65 APPLICATION SITE IRRITATION 1273 0.1022
66 RIGHT VENTRICULAR HYPERTROPHY 92 0.1019
67 APPLICATION SITE SCAB 217 0.1004
68 BENIGN PROSTATIC HYPERPLASIA 517 0.1000
69 RETROGRADE EJACULATION 79 0.0996
70 DISTURBANCE IN SEXUAL AROUSAL 72 0.0783
71 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 159 0.0779
72 PULMONARY FUNCTION TEST ABNORMAL 120 0.0770
73 BRONCHIAL SECRETION RETENTION 97 0.0761
74 PROSTATOMEGALY 292 0.0742
75 ANORGASMIA 197 0.0725
76 PROSTATITIS 214 0.0703
77 EPIDIDYMITIS 80 0.0687
78 NIPPLE PAIN 133 0.0653
79 ENDOCRINE DISORDER 83 0.0647
80 RESPIRATORY SYMPTOM 184 0.0646
81 BLOOD TESTOSTERONE DECREASED 432 0.0631
82 AORTIC VALVE STENOSIS 109 0.0611
83 HYDROCELE 64 0.0600
84 URINARY TRACT DISORDER 260 0.0577
85 GENITAL PAIN 82 0.0554
86 DRUG DISPENSED TO WRONG PATIENT 51 0.0535
87 APPLICATION SITE PAIN 1140 0.0517
88 URINE FLOW DECREASED 121 0.0506
89 MUSCLE ATROPHY 619 0.0488
90 CONTRAINDICATED PRODUCT PRESCRIBED 81 0.0482
91 FORCED EXPIRATORY VOLUME DECREASED 136 0.0480
92 GINGIVAL RECESSION 92 0.0478
93 APPLICATION SITE PARAESTHESIA 62 0.0475
94 ESSENTIAL HYPERTENSION 86 0.0469
95 HYPERPARATHYROIDISM SECONDARY 117 0.0467
96 APPLICATION SITE INFLAMMATION 64 0.0462
97 ARTERIOSCLEROSIS CORONARY ARTERY 303 0.0457
98 PROSTATIC OPERATION 55 0.0456
99 INFERTILITY 67 0.0445
100 HORMONE LEVEL ABNORMAL 215 0.0440
101 PENILE PAIN 130 0.0427
102 NEPHROGENIC ANAEMIA 194 0.0418
103 DEPRESSION SUICIDAL 143 0.0413
104 BREAST ENLARGEMENT 133 0.0406
105 FULL BLOOD COUNT ABNORMAL 426 0.0402
106 HAEMORRHAGIC STROKE 312 0.0399
107 SEBORRHOEIC DERMATITIS 66 0.0399
108 ARTERIOSCLEROSIS 371 0.0394
109 DIASTOLIC DYSFUNCTION 119 0.0385
110 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 702 0.0383
111 APPLICATION SITE DISCOMFORT 66 0.0367
112 GENERALISED ANXIETY DISORDER 53 0.0360
113 COGNITIVE DISORDER 1601 0.0343
114 DARK CIRCLES UNDER EYES 50 0.0340
115 HAIR TEXTURE ABNORMAL 452 0.0338
116 PULMONARY ALVEOLAR HAEMORRHAGE 188 0.0335
117 CHEST X-RAY ABNORMAL 102 0.0332
118 NEUROLOGICAL SYMPTOM 189 0.0330
119 APPLICATION SITE RASH 449 0.0326
120 OBSTRUCTIVE AIRWAYS DISORDER 361 0.0324
121 BRAIN FOG 487 0.0310
122 FLAT AFFECT 71 0.0306
123 PROSTATIC DISORDER 169 0.0306
124 EMOTIONAL POVERTY 52 0.0296
125 HAIR GROWTH ABNORMAL 200 0.0289
126 URINARY TRACT OBSTRUCTION 67 0.0282
127 OBSTRUCTION 112 0.0280
128 DEREALISATION 60 0.0279
129 HAIR COLOUR CHANGES 342 0.0275
130 ACTINIC KERATOSIS 70 0.0269
131 NODULE 350 0.0268
132 NOCTURIA 324 0.0267
133 ANHEDONIA 691 0.0263
134 HAEMORRHAGE URINARY TRACT 66 0.0259
135 URINARY HESITATION 61 0.0255
136 SEBORRHOEA 93 0.0253
137 OCULAR DISCOMFORT 283 0.0252
138 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 421 0.0248
139 BRONCHIECTASIS 167 0.0248
140 BLOOD TESTOSTERONE INCREASED 53 0.0246
141 APPLICATION SITE ERYTHEMA 646 0.0246
142 SELF ESTEEM DECREASED 59 0.0243
143 GYNAECOMASTIA 730 0.0236
144 TACHYARRHYTHMIA 58 0.0232
145 TRICHORRHEXIS 64 0.0229
146 MAJOR DEPRESSION 166 0.0227
147 REBOUND ACID HYPERSECRETION 68 0.0225
148 HYPERTONIC BLADDER 64 0.0221
149 SKIN ATROPHY 127 0.0220
150 DECREASED INTEREST 129 0.0219
151 SLEEP APNOEA SYNDROME 409 0.0214
152 HAEMATURIA 731 0.0213
153 APPLICATION SITE BURN 104 0.0211
154 GENERALISED OEDEMA 260 0.0210
155 SKIN WRINKLING 57 0.0209
156 APPLICATION SITE HAEMORRHAGE 57 0.0208
157 APATHY 304 0.0208
158 MELANOCYTIC NAEVUS 91 0.0207
159 RENAL CYST 164 0.0206
160 BREAST SWELLING 55 0.0204
161 ORTHOSTATIC HYPOTENSION 356 0.0204
162 HYPERLIPIDAEMIA 242 0.0202
163 PROSTATIC SPECIFIC ANTIGEN INCREASED 279 0.0202
164 URINARY RETENTION 669 0.0200
165 AORTIC ARTERIOSCLEROSIS 51 0.0198
166 END STAGE RENAL DISEASE 361 0.0198
167 HEAD DISCOMFORT 347 0.0196
168 INTERVERTEBRAL DISC DEGENERATION 181 0.0195
169 LISTLESS 63 0.0191
170 SUICIDAL IDEATION 1747 0.0191
171 APPLICATION SITE VESICLES 123 0.0189
172 BRAIN INJURY 190 0.0189
173 SOCIAL AVOIDANT BEHAVIOUR 107 0.0185
174 ADVERSE EVENT 1695 0.0184
175 DYSURIA 674 0.0183
176 LEFT VENTRICULAR HYPERTROPHY 78 0.0182
177 INGUINAL HERNIA 110 0.0181
178 BREAST TENDERNESS 134 0.0178
179 DEPRESSION 4002 0.0176
180 RHINITIS ALLERGIC 78 0.0175
181 AUTONOMIC NERVOUS SYSTEM IMBALANCE 50 0.0171
182 DRUG ADMINISTERED AT INAPPROPRIATE SITE 180 0.0171
183 MICTURITION URGENCY 193 0.0169
184 FOOD INTOLERANCE 61 0.0166
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 71 0.0164
186 GROIN PAIN 142 0.0162
187 HAEMORRHAGIC ANAEMIA 71 0.0161
188 AORTIC VALVE INCOMPETENCE 68 0.0160
189 BREAST MASS 107 0.0159
190 BRADYPHRENIA 104 0.0159
191 PROSTATE CANCER METASTATIC 53 0.0158
192 TINNITUS 727 0.0158
193 PRESYNCOPE 384 0.0158
194 ALTERED STATE OF CONSCIOUSNESS 342 0.0158
195 PRODUCTIVE COUGH 735 0.0154
196 GOUT 272 0.0151
197 RALES 88 0.0151
198 DIVERTICULUM INTESTINAL 66 0.0151
199 AFFECTIVE DISORDER 118 0.0150
200 PRODUCT FORMULATION ISSUE 98 0.0148
201 PANIC ATTACK 539 0.0148
202 VASCULITIS 172 0.0148
203 BUNDLE BRANCH BLOCK RIGHT 67 0.0146
204 POLLAKIURIA 608 0.0146
205 HYPERCHOLESTEROLAEMIA 140 0.0145
206 BREAST PAIN 152 0.0142
207 PHOTOPHOBIA 268 0.0142
208 PSYCHIATRIC SYMPTOM 105 0.0142
209 HAEMATEMESIS 360 0.0142
210 DIPLOPIA 366 0.0141
211 SPINAL STENOSIS 57 0.0138
212 HYPOXIA 486 0.0138
213 BREATH SOUNDS ABNORMAL 68 0.0138
214 SKIN PAPILLOMA 55 0.0137
215 LARGE INTESTINE POLYP 95 0.0137
216 EXPIRED PRODUCT ADMINISTERED 451 0.0136
217 HOSPICE CARE 134 0.0136
218 SENSORY LOSS 109 0.0135
219 ATRIAL FLUTTER 108 0.0135
220 FREEZING PHENOMENON 50 0.0135
221 SNORING 51 0.0135
222 DIZZINESS POSTURAL 130 0.0134
223 ABNORMAL LOSS OF WEIGHT 91 0.0133
224 PHYSICAL DISABILITY 59 0.0133
225 APPLICATION SITE REACTION 93 0.0132
226 PANIC DISORDER 51 0.0132
227 HAEMOPTYSIS 356 0.0127
228 ANXIETY 3592 0.0126
229 CHRONIC KIDNEY DISEASE 952 0.0125
230 DEPRESSED MOOD 658 0.0124
231 VITAMIN D DEFICIENCY 121 0.0124
232 DISTURBANCE IN ATTENTION 668 0.0124
233 DIVERTICULUM 88 0.0124
234 LOWER GASTROINTESTINAL HAEMORRHAGE 91 0.0123
235 WHEEZING 729 0.0123
236 BLOOD URINE PRESENT 233 0.0123
237 ATRIAL FIBRILLATION 1190 0.0122
238 CARDIAC FAILURE CHRONIC 52 0.0122
239 PULMONARY FIBROSIS 234 0.0122
240 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 581 0.0121
241 DYSLIPIDAEMIA 61 0.0120
242 SPINAL OSTEOARTHRITIS 105 0.0119
243 UPPER GASTROINTESTINAL HAEMORRHAGE 200 0.0119
244 RENAL FAILURE CHRONIC 90 0.0117
245 ANGINA UNSTABLE 76 0.0117
246 SUBDURAL HAEMATOMA 167 0.0117
247 MUSCLE TWITCHING 268 0.0116
248 CORONARY ARTERY STENOSIS 58 0.0115
249 HALLUCINATION, VISUAL 243 0.0115
250 VITREOUS FLOATERS 112 0.0114
251 NONSPECIFIC REACTION 62 0.0113
252 ON AND OFF PHENOMENON 61 0.0110
253 HAEMORRHOIDS 214 0.0110
254 BOWEL MOVEMENT IRREGULARITY 84 0.0110
255 OLIGURIA 68 0.0109
256 EXERCISE TOLERANCE DECREASED 63 0.0109
257 CARDIAC TAMPONADE 52 0.0109
258 SQUAMOUS CELL CARCINOMA OF SKIN 66 0.0109
259 DYSPNOEA EXERTIONAL 410 0.0109
260 PEMPHIGOID 82 0.0109
261 DRUG ADMINISTRATION ERROR 333 0.0108
262 SKIN TIGHTNESS 51 0.0108
263 ASCITES 316 0.0107
264 VARICOSE VEIN 55 0.0106
265 PERIORBITAL SWELLING 59 0.0104
266 HALLUCINATION 786 0.0104
267 HYPOTHYROIDISM 333 0.0104
268 PAPULE 73 0.0104
269 LACERATION 97 0.0103
270 PERICARDIAL EFFUSION 238 0.0103
271 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 91 0.0103
272 SWELLING OF EYELID 64 0.0102
273 MUSCLE DISORDER 82 0.0101
274 AMNESIA 657 0.0101
275 INSOMNIA 2687 0.0101
276 BODY HEIGHT DECREASED 107 0.0100
277 VENTRICULAR EXTRASYSTOLES 103 0.0099
278 MYOPATHY 85 0.0098
279 MENTAL IMPAIRMENT 238 0.0098
280 AORTIC ANEURYSM 74 0.0097
281 MUSCLE STRAIN 84 0.0097
282 URINE ODOUR ABNORMAL 57 0.0097
283 BASAL CELL CARCINOMA 149 0.0095
284 BODY TEMPERATURE DECREASED 94 0.0095
285 QUALITY OF LIFE DECREASED 128 0.0095
286 MEDICATION ERROR 527 0.0095
287 CLOSTRIDIUM DIFFICILE COLITIS 100 0.0094
288 BLOOD POTASSIUM INCREASED 153 0.0094
289 SYNCOPE 942 0.0094
290 ATRIOVENTRICULAR BLOCK 72 0.0093
291 SLEEP DISORDER 655 0.0093
292 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 660 0.0093
293 SPLENOMEGALY 108 0.0092
294 GASTROOESOPHAGEAL REFLUX DISEASE 737 0.0091
295 THINKING ABNORMAL 170 0.0091
296 OBSESSIVE-COMPULSIVE DISORDER 73 0.0091
297 EYE PAIN 510 0.0090
298 BLOOD PRESSURE FLUCTUATION 216 0.0090
299 OBESITY 143 0.0090
300 HEPATITIS CHOLESTATIC 54 0.0090
301 TRICUSPID VALVE INCOMPETENCE 71 0.0089
302 BLOOD COUNT ABNORMAL 135 0.0089
303 ATELECTASIS 86 0.0089
304 WRONG PRODUCT ADMINISTERED 60 0.0089
305 BLOOD PRESSURE SYSTOLIC INCREASED 173 0.0089
306 BACK INJURY 96 0.0088
307 ROTATOR CUFF SYNDROME 113 0.0088
308 RESTLESS LEGS SYNDROME 159 0.0087
309 CARDIAC PACEMAKER INSERTION 52 0.0087
310 PERSONALITY CHANGE 81 0.0087
311 ACUTE MYOCARDIAL INFARCTION 257 0.0087
312 INTERNATIONAL NORMALISED RATIO INCREASED 248 0.0087
313 LIGAMENT SPRAIN 86 0.0087
314 BLINDNESS 354 0.0087
315 TROPONIN INCREASED 66 0.0087
316 UROSEPSIS 80 0.0087
317 CARDIAC MURMUR 75 0.0087
318 CARDIO-RESPIRATORY ARREST 362 0.0086
319 ANGINA PECTORIS 248 0.0086
320 DUODENAL ULCER 61 0.0086
321 URINARY INCONTINENCE 256 0.0086
322 CARDIAC FAILURE CONGESTIVE 692 0.0086
323 CORONARY ARTERY DISEASE 260 0.0086
324 INCONTINENCE 90 0.0085
325 ALOPECIA 1670 0.0085
326 DELUSION 132 0.0085
327 HEART RATE IRREGULAR 192 0.0085
328 BLOOD MAGNESIUM DECREASED 73 0.0085
329 ACUTE KIDNEY INJURY 1294 0.0084
330 FAECES DISCOLOURED 183 0.0084
331 PROCTALGIA 54 0.0084
332 IMPAIRED QUALITY OF LIFE 120 0.0083
333 PERIPHERAL COLDNESS 114 0.0083
334 BLADDER DISORDER 82 0.0082
335 IRON DEFICIENCY ANAEMIA 76 0.0082
336 DEMENTIA 230 0.0082
337 HYPERKALAEMIA 288 0.0082
338 ECCHYMOSIS 56 0.0082
339 MOOD SWINGS 260 0.0081
340 BLOOD UREA INCREASED 136 0.0081
341 RED BLOOD CELL COUNT DECREASED 232 0.0081
342 PRODUCT ADMINISTRATION ERROR 164 0.0081
343 BLOOD IRON DECREASED 96 0.0081
344 THROMBOSIS 650 0.0081
345 POST PROCEDURAL HAEMORRHAGE 94 0.0081
346 POLYURIA 66 0.0081
347 MOOD ALTERED 218 0.0080
348 MITRAL VALVE INCOMPETENCE 90 0.0079
349 RIB FRACTURE 163 0.0079
350 MYASTHENIA GRAVIS 64 0.0079
351 MIDDLE INSOMNIA 146 0.0078
352 POOR QUALITY SLEEP 167 0.0077
353 SQUAMOUS CELL CARCINOMA 73 0.0077
354 BRADYCARDIA 411 0.0077
355 ASTHENIA 2911 0.0077
356 KNEE OPERATION 76 0.0077
357 DERMATITIS CONTACT 88 0.0077
358 BALANCE DISORDER 665 0.0077
359 CONFUSIONAL STATE 1240 0.0077
360 ANAL INCONTINENCE 69 0.0077
361 LETHARGY 439 0.0076
362 JOINT INJURY 163 0.0076
363 SCAB 87 0.0076
364 HYPOACUSIS 327 0.0076
365 OSTEOPOROSIS 310 0.0075
366 BLOOD PRESSURE INCREASED 1151 0.0075
367 RECTAL HAEMORRHAGE 323 0.0075
368 ARRHYTHMIA 356 0.0075
369 CORONARY ARTERY OCCLUSION 103 0.0075
370 PARKINSONISM 73 0.0075
371 PANIC REACTION 54 0.0075
372 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 390 0.0075
373 MYOSITIS 67 0.0075
374 INTERNAL HAEMORRHAGE 85 0.0074
375 HICCUPS 61 0.0074
376 MENTAL DISORDER 322 0.0074
377 FULL BLOOD COUNT DECREASED 149 0.0074
378 INCREASED TENDENCY TO BRUISE 68 0.0074
379 MUSCULAR WEAKNESS 839 0.0074
380 DIZZINESS 3669 0.0073
381 ASTHMA 827 0.0073
382 FALL 2433 0.0073
383 PALPITATIONS 853 0.0073
384 SKIN LACERATION 79 0.0073
385 TRANSIENT ISCHAEMIC ATTACK 245 0.0073
386 AGEUSIA 181 0.0072
387 RENAL FAILURE 963 0.0072
388 SINUS BRADYCARDIA 70 0.0072
389 DECUBITUS ULCER 59 0.0072
390 DYSSTASIA 211 0.0072
391 ACUTE RESPIRATORY FAILURE 139 0.0072
392 ASPIRATION 79 0.0072
393 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 513 0.0072
394 SEASONAL ALLERGY 102 0.0072
395 ABNORMAL FAECES 59 0.0072
396 GLOMERULAR FILTRATION RATE DECREASED 88 0.0072
397 HAEMATOCRIT DECREASED 142 0.0072
398 FLANK PAIN 67 0.0071
399 VENTRICULAR TACHYCARDIA 118 0.0071
400 CONSTIPATION 1546 0.0071
401 PRODUCT PRESCRIBING ISSUE 154 0.0071
402 DRUG INEFFECTIVE 9309 0.0071
403 MELAENA 155 0.0070
404 HEART RATE DECREASED 247 0.0070
405 GASTROINTESTINAL HAEMORRHAGE 587 0.0070
406 HEAD INJURY 222 0.0070
407 HAEMOGLOBIN DECREASED 719 0.0070
408 OEDEMA PERIPHERAL 851 0.0070
409 MYALGIA 1187 0.0070
410 PULMONARY EMBOLISM 663 0.0070
411 SEPSIS 777 0.0070
412 COMA 331 0.0069
413 INITIAL INSOMNIA 71 0.0069
414 EAR DISCOMFORT 71 0.0069
415 CARDIOMEGALY 85 0.0069
416 HOT FLUSH 520 0.0069
417 HYPOTENSION 1384 0.0069
418 LUNG DISORDER 338 0.0069
419 BLOOD PRESSURE DECREASED 457 0.0069
420 ECONOMIC PROBLEM 104 0.0069
421 NEPHROLITHIASIS 314 0.0068
422 RENAL INJURY 203 0.0068
423 SKIN CANCER 147 0.0068
424 PRODUCT COMMUNICATION ISSUE 60 0.0068
425 MYOCLONUS 81 0.0068
426 EMOTIONAL DISORDER 209 0.0068
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1221 0.0068
428 PRODUCT ADMINISTRATION INTERRUPTED 53 0.0067
429 BLOOD CREATININE INCREASED 440 0.0067
430 INTERVERTEBRAL DISC PROTRUSION 147 0.0067
431 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 69 0.0067
432 DRUG EFFECT LESS THAN EXPECTED 99 0.0067
433 UPPER-AIRWAY COUGH SYNDROME 55 0.0067
434 TACHYCARDIA 592 0.0067
435 TASTE DISORDER 135 0.0066
436 SWELLING FACE 433 0.0066
437 VISION BLURRED 911 0.0066
438 HYPERTENSION 1397 0.0066
439 SKIN EXFOLIATION 556 0.0066
440 TUBULOINTERSTITIAL NEPHRITIS 123 0.0066
441 FATIGUE 5098 0.0065
442 HYPOMAGNESAEMIA 91 0.0065
443 CYST 81 0.0065
444 BLOOD SODIUM DECREASED 123 0.0065
445 TENDONITIS 101 0.0065
446 HERNIA 126 0.0065
447 CHROMATURIA 147 0.0065
448 TEMPERATURE INTOLERANCE 67 0.0065
449 TENDON RUPTURE 80 0.0065
450 DRUG INTERACTION 1025 0.0065
451 PLEURAL EFFUSION 391 0.0064
452 CONDITION AGGRAVATED 1953 0.0064
453 PELVIC FRACTURE 50 0.0064
454 LIMB INJURY 174 0.0064
455 DECREASED APPETITE 1487 0.0064
456 BLOOD PRESSURE ABNORMAL 127 0.0064
457 CHEST PAIN 1183 0.0064
458 SKIN DISORDER 212 0.0063
459 OSTEOPENIA 96 0.0063
460 HYPERSOMNIA 181 0.0063
461 URINARY TRACT INFECTION 1075 0.0063
462 HAEMORRHAGE INTRACRANIAL 94 0.0063
463 SLUGGISHNESS 64 0.0063
464 MALIGNANT MELANOMA 84 0.0063
465 ANGER 212 0.0063
466 VERTIGO 382 0.0063
467 SOPOR 83 0.0063
468 LIVER FUNCTION TEST ABNORMAL 182 0.0063
469 LUNG INFILTRATION 55 0.0062
470 FLATULENCE 353 0.0062
471 DRY EYE 309 0.0062
472 FLUID RETENTION 312 0.0061
473 MEMORY IMPAIRMENT 842 0.0061
474 PNEUMONIA ASPIRATION 153 0.0061
475 HEPATIC STEATOSIS 114 0.0061
476 FLUID OVERLOAD 89 0.0061
477 SPUTUM DISCOLOURED 58 0.0061
478 URINE OUTPUT DECREASED 53 0.0061
479 OSTEOARTHRITIS 257 0.0061
480 NEUROPATHY PERIPHERAL 575 0.0060
481 EPISTAXIS 452 0.0060
482 WRONG TECHNIQUE IN DRUG USAGE PROCESS 219 0.0060
483 DECREASED ACTIVITY 65 0.0060
484 CONTRAINDICATED PRODUCT ADMINISTERED 182 0.0060
485 PERIPHERAL SWELLING 926 0.0060
486 BLOOD CREATINE PHOSPHOKINASE INCREASED 173 0.0060
487 LOCALISED INFECTION 145 0.0060
488 DYSPNOEA 3393 0.0060
489 PULMONARY OEDEMA 268 0.0060
490 VITAMIN D DECREASED 51 0.0060
491 DYSARTHRIA 224 0.0059
492 HIATUS HERNIA 77 0.0059
493 NERVE INJURY 66 0.0059
494 DYSPEPSIA 584 0.0059
495 RHINORRHOEA 383 0.0059
496 LIP SWELLING 197 0.0059
497 DYSPHAGIA 561 0.0059
498 DISORIENTATION 234 0.0059
499 MYOCARDIAL ISCHAEMIA 67 0.0059
500 DELIRIUM 204 0.0059
501 SKIN SWELLING 51 0.0059
502 NIGHTMARE 203 0.0059
503 NECK PAIN 327 0.0058
504 NIGHT SWEATS 188 0.0058
505 SKIN LESION 160 0.0058
506 CHOLELITHIASIS 191 0.0058
507 NEURALGIA 141 0.0058
508 SENSORY DISTURBANCE 93 0.0058
509 ANAEMIA 1105 0.0058
510 COLD SWEAT 102 0.0058
511 SINUS DISORDER 114 0.0058
512 HYPERTENSIVE CRISIS 64 0.0057
513 HEART RATE INCREASED 568 0.0057
514 OXYGEN SATURATION DECREASED 322 0.0057
515 RESTLESSNESS 209 0.0057
516 THIRST 102 0.0057
517 PULMONARY MASS 85 0.0057
518 SKIN IRRITATION 261 0.0057
519 PROSTATE CANCER 458 0.0057
520 SOMNOLENCE 1145 0.0057
521 NEPHROPATHY 53 0.0057
522 MYELODYSPLASTIC SYNDROME 82 0.0057
523 CHILLS 663 0.0057
524 MASS 79 0.0056
525 WEIGHT FLUCTUATION 59 0.0056
526 MUSCULOSKELETAL DISCOMFORT 97 0.0056
527 WEIGHT DECREASED 1572 0.0056
528 APHASIA 170 0.0056
529 PARANOIA 97 0.0056
530 MUSCULOSKELETAL CHEST PAIN 87 0.0056
531 HYPOTONIA 56 0.0056
532 SMALL INTESTINAL OBSTRUCTION 69 0.0056
533 WHITE BLOOD CELL COUNT INCREASED 215 0.0056
534 BACK DISORDER 91 0.0056
535 HYPERTHYROIDISM 81 0.0056
536 MENTAL STATUS CHANGES 155 0.0056
537 RENAL IMPAIRMENT 468 0.0056
538 JOINT STIFFNESS 146 0.0056
539 PNEUMONIA BACTERIAL 51 0.0056
540 TRANSFUSION 58 0.0055
541 CEREBRAL HAEMORRHAGE 198 0.0055
542 NERVE COMPRESSION 51 0.0055
543 COUGH 1548 0.0055
544 AGGRESSION 276 0.0055
545 DRY SKIN 736 0.0055
546 PHOTOSENSITIVITY REACTION 91 0.0055
547 DRY THROAT 56 0.0055
548 EYE SWELLING 204 0.0055
549 INTRAOCULAR PRESSURE INCREASED 70 0.0055
550 LUNG INFECTION 85 0.0055
551 EJECTION FRACTION DECREASED 85 0.0055
552 CATARACT 325 0.0055
553 IRRITABLE BOWEL SYNDROME 117 0.0055
554 CYSTITIS 173 0.0054
555 BACK PAIN 1262 0.0054
556 LYMPHADENOPATHY 192 0.0054
557 CELLULITIS 273 0.0054
558 SALIVARY HYPERSECRETION 54 0.0054
559 UNDERDOSE 394 0.0054
560 SKIN DISCOLOURATION 248 0.0054
561 ECZEMA 282 0.0054
562 MUSCLE TIGHTNESS 87 0.0054
563 DYSPHONIA 314 0.0054
564 GASTROINTESTINAL PAIN 59 0.0054
565 RENAL FAILURE ACUTE 227 0.0053
566 OEDEMA 290 0.0053
567 GINGIVAL BLEEDING 73 0.0053
568 COMPLETED SUICIDE 445 0.0053
569 ABDOMINAL PAIN LOWER 135 0.0053
570 COVID-19 PNEUMONIA 63 0.0053
571 PLATELET COUNT DECREASED 568 0.0053
572 SKIN REACTION 75 0.0053
573 DRY MOUTH 431 0.0053
574 OSTEOMYELITIS 96 0.0053
575 IRRITABILITY 318 0.0053
576 HYPERSENSITIVITY 979 0.0053
577 SCIATICA 84 0.0053
578 CONTUSION 507 0.0053
579 HIP FRACTURE 169 0.0052
580 GAIT DISTURBANCE 1005 0.0052
581 DEHYDRATION 699 0.0052
582 SUPRAVENTRICULAR TACHYCARDIA 50 0.0052
583 SKIN ULCER 135 0.0052
584 SUBARACHNOID HAEMORRHAGE 53 0.0052
585 PLASMA CELL MYELOMA 203 0.0052
586 SKIN HAEMORRHAGE 77 0.0052
587 THERAPY CHANGE 51 0.0052
588 PULMONARY HYPERTENSION 108 0.0052
589 MALNUTRITION 58 0.0052
590 AGITATION 379 0.0052
591 CHEST DISCOMFORT 528 0.0052
592 PNEUMONIA 1667 0.0051
593 CARPAL TUNNEL SYNDROME 72 0.0051
594 GLAUCOMA 99 0.0051
595 FEELING COLD 143 0.0051
596 HAEMATOMA 133 0.0051
597 RHABDOMYOLYSIS 214 0.0051
598 PSYCHOTIC DISORDER 151 0.0051
599 FEELING ABNORMAL 1224 0.0051
600 TOOTH ABSCESS 52 0.0051
601 ELECTROLYTE IMBALANCE 59 0.0051
602 HYPOCALCAEMIA 96 0.0051
603 BLOOD CALCIUM DECREASED 57 0.0051
604 DYSKINESIA 206 0.0051
605 ERUCTATION 98 0.0051
606 THYROID DISORDER 78 0.0051
607 BLOOD POTASSIUM DECREASED 152 0.0051
608 DIARRHOEA 3255 0.0050
609 CLOSTRIDIUM DIFFICILE INFECTION 110 0.0050
610 THERAPEUTIC RESPONSE UNEXPECTED 226 0.0050
611 ORAL DISCOMFORT 70 0.0050
612 UNRESPONSIVE TO STIMULI 130 0.0050
613 MUSCULOSKELETAL PAIN 263 0.0050
614 HYPOPHAGIA 128 0.0050
615 RENAL PAIN 53 0.0050
616 SKIN INFECTION 56 0.0050
617 PRURITUS 1917 0.0050
618 HYPOKALAEMIA 230 0.0050
619 SPEECH DISORDER 261 0.0050
620 RENAL DISORDER 232 0.0050
621 LEUKOCYTOSIS 90 0.0050
622 EMPHYSEMA 50 0.0050
623 COORDINATION ABNORMAL 69 0.0049
624 DEAFNESS 129 0.0049
625 SCRATCH 52 0.0049
626 DERMATITIS 103 0.0049
627 RASH PAPULAR 110 0.0049
628 DEVICE OCCLUSION 69 0.0049
629 HEADACHE 3074 0.0049
630 EYE IRRITATION 282 0.0049
631 CARDIAC FAILURE 392 0.0049
632 ABDOMINAL DISTENSION 509 0.0049
633 FOOT DEFORMITY 54 0.0049
634 PULMONARY THROMBOSIS 53 0.0049
635 IMMUNE SYSTEM DISORDER 64 0.0049
636 PULMONARY CONGESTION 64 0.0048
637 PALLOR 132 0.0048
638 HYPOAESTHESIA 726 0.0048
639 BLOOD ALKALINE PHOSPHATASE INCREASED 120 0.0048
640 ORAL PAIN 108 0.0048
641 HYPOKINESIA 70 0.0048
642 ABNORMAL DREAMS 133 0.0048
643 PRESCRIBED UNDERDOSE 96 0.0048
644 TOOTH FRACTURE 53 0.0048
645 BACTERAEMIA 57 0.0048
646 THERAPY CESSATION 246 0.0048
647 PAIN IN EXTREMITY 1408 0.0048
648 PANCYTOPENIA 267 0.0048
649 FOLLICULITIS 50 0.0048
650 DIVERTICULITIS 132 0.0048
651 OESOPHAGITIS 52 0.0048
652 PHARYNGITIS 59 0.0048
653 CIRCULATORY COLLAPSE 81 0.0048
654 ABDOMINAL PAIN 1104 0.0047
655 ARTHRALGIA 1971 0.0047
656 CARDIOMYOPATHY 70 0.0047
657 FEEDING DISORDER 96 0.0047
658 EAR PAIN 92 0.0047
659 RASH PRURITIC 256 0.0047
660 SECRETION DISCHARGE 59 0.0047
661 WEIGHT INCREASED 1049 0.0047
662 MUSCLE RIGIDITY 56 0.0047
663 CARDIAC DISORDER 438 0.0047
664 MOBILITY DECREASED 336 0.0047
665 BLISTER 262 0.0047
666 BLOOD CHOLESTEROL INCREASED 217 0.0047
667 GAMMA-GLUTAMYLTRANSFERASE INCREASED 103 0.0046
668 NERVOUS SYSTEM DISORDER 145 0.0046
669 CHOLECYSTECTOMY 53 0.0046
670 POST PROCEDURAL COMPLICATION 89 0.0046
671 ATAXIA 55 0.0046
672 PROTEINURIA 88 0.0046
673 RASH 2014 0.0046
674 DYSGEUSIA 343 0.0046
675 HYPONATRAEMIA 260 0.0046
676 BONE DISORDER 84 0.0046
677 DEEP VEIN THROMBOSIS 299 0.0046
678 GASTRITIS 121 0.0046
679 RESPIRATORY TRACT CONGESTION 73 0.0046
680 BONE LOSS 69 0.0046
681 MUSCLE SPASMS 842 0.0046
682 TOOTH DISORDER 102 0.0046
683 TREMOR 761 0.0046
684 GASTRIC ULCER 87 0.0046
685 LACRIMATION INCREASED 138 0.0046
686 COAGULOPATHY 76 0.0046
687 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 921 0.0045
688 LOSS OF CONSCIOUSNESS 582 0.0045
689 BLOOD TRIGLYCERIDES INCREASED 80 0.0045
690 OFF LABEL USE 3950 0.0045
691 PRODUCT USE COMPLAINT 71 0.0045
692 UPPER RESPIRATORY TRACT INFECTION 208 0.0045
693 ANOSMIA 65 0.0045
694 BRONCHITIS 332 0.0045
695 GLYCOSYLATED HAEMOGLOBIN INCREASED 113 0.0045
696 JOINT RANGE OF MOTION DECREASED 60 0.0045
697 THROAT TIGHTNESS 121 0.0045
698 LABORATORY TEST ABNORMAL 132 0.0045
699 SPINAL OPERATION 55 0.0045
700 JAUNDICE 120 0.0045
701 HYPERCALCAEMIA 55 0.0044
702 ASPARTATE AMINOTRANSFERASE INCREASED 236 0.0044
703 PRODUCT USE ISSUE 833 0.0044
704 ACNE 336 0.0044
705 THROMBOCYTOPENIA 494 0.0044
706 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 242 0.0044
707 FREQUENT BOWEL MOVEMENTS 119 0.0044
708 ANKLE FRACTURE 68 0.0044
709 SWOLLEN TONGUE 137 0.0044
710 ADVERSE REACTION 58 0.0044
711 DIALYSIS 62 0.0044
712 PRODUCT PRESCRIBING ERROR 104 0.0044
713 ACUTE MYELOID LEUKAEMIA 68 0.0044
714 ENCEPHALOPATHY 107 0.0044
715 DEPRESSED LEVEL OF CONSCIOUSNESS 172 0.0043
716 GASTRIC HAEMORRHAGE 50 0.0043
717 WHITE BLOOD CELL COUNT DECREASED 470 0.0043
718 HAEMORRHAGE 449 0.0043
719 RASH MACULAR 150 0.0043
720 BONE PAIN 251 0.0043
721 ABDOMINAL PAIN UPPER 882 0.0043
722 PARAESTHESIA 673 0.0043
723 TYPE 2 DIABETES MELLITUS 144 0.0043
724 INCORRECT DOSE ADMINISTERED 971 0.0042
725 GENERAL PHYSICAL HEALTH DETERIORATION 492 0.0042
726 FEELING JITTERY 81 0.0042
727 GAIT INABILITY 142 0.0042
728 HYPOGLYCAEMIA 206 0.0042
729 HYPERHIDROSIS 544 0.0042
730 LOWER RESPIRATORY TRACT INFECTION 192 0.0042
731 THERAPEUTIC PRODUCT EFFECT DECREASED 189 0.0042
732 DERMATITIS ALLERGIC 53 0.0042
733 RESPIRATORY FAILURE 307 0.0042
734 METASTASES TO BONE 69 0.0042
735 CHOKING 82 0.0042
736 FEAR 113 0.0042
737 NASAL CONGESTION 246 0.0042
738 WOUND 117 0.0042
739 BEDRIDDEN 55 0.0042
740 TOOTH EXTRACTION 52 0.0042
741 INTENTIONAL DOSE OMISSION 119 0.0042
742 PRURITUS GENERALISED 90 0.0042
743 ARTHRITIS 327 0.0042
744 ARTHROPATHY 231 0.0042
745 DISEASE RECURRENCE 196 0.0041
746 PNEUMONITIS 112 0.0041
747 PNEUMOTHORAX 65 0.0041
748 HAEMATOCHEZIA 226 0.0041
749 PAIN IN JAW 116 0.0041
750 CEREBRAL INFARCTION 100 0.0041
751 PARAESTHESIA ORAL 59 0.0041
752 TOOTHACHE 74 0.0041
753 COVID-19 717 0.0041
754 OROPHARYNGEAL PAIN 378 0.0041
755 ALANINE AMINOTRANSFERASE INCREASED 250 0.0041
756 RESPIRATORY TRACT INFECTION 106 0.0041
757 PLATELET COUNT INCREASED 53 0.0041
758 CEREBROVASCULAR ACCIDENT 685 0.0040
759 GASTROENTERITIS 59 0.0040
760 SURGERY 237 0.0040
761 BLOOD BILIRUBIN INCREASED 109 0.0040
762 PRODUCT SUBSTITUTION ISSUE 232 0.0040
763 DEVICE RELATED INFECTION 62 0.0040
764 APHONIA 56 0.0040
765 PRODUCT DISPENSING ERROR 87 0.0040
766 ROAD TRAFFIC ACCIDENT 167 0.0040
767 LIMB DISCOMFORT 123 0.0040
768 DIABETES MELLITUS INADEQUATE CONTROL 70 0.0039
769 KNEE ARTHROPLASTY 83 0.0039
770 VISUAL IMPAIRMENT 488 0.0039
771 SCAR 67 0.0039
772 BACTERIAL INFECTION 73 0.0039
773 STAPHYLOCOCCAL INFECTION 129 0.0039
774 EYE HAEMORRHAGE 52 0.0039
775 COLON CANCER 58 0.0039
776 INTENTIONAL PRODUCT USE ISSUE 340 0.0039
777 INFUSION SITE PAIN 50 0.0039
778 INCORRECT PRODUCT ADMINISTRATION DURATION 84 0.0039
779 INCORRECT DRUG ADMINISTRATION DURATION 109 0.0039
780 MALAISE 1698 0.0039
781 ABDOMINAL DISCOMFORT 645 0.0038
782 BODY TEMPERATURE INCREASED 78 0.0038
783 GALLBLADDER DISORDER 68 0.0038
784 EATING DISORDER 81 0.0038
785 FACE OEDEMA 64 0.0038
786 VISUAL ACUITY REDUCED 126 0.0038
787 IMPAIRED WORK ABILITY 81 0.0038
788 SINUS CONGESTION 51 0.0038
789 ULCER 60 0.0038
790 MANIA 62 0.0038
791 ISCHAEMIC STROKE 67 0.0038
792 TACHYPNOEA 51 0.0037
793 BLOOD LACTATE DEHYDROGENASE INCREASED 59 0.0037
794 RASH ERYTHEMATOUS 178 0.0037
795 THROAT IRRITATION 167 0.0037
796 FLUSHING 378 0.0037
797 ELECTROCARDIOGRAM QT PROLONGED 133 0.0037
798 THERAPY INTERRUPTED 264 0.0037
799 CARDIOGENIC SHOCK 53 0.0037
800 MYOCARDIAL INFARCTION 643 0.0037
801 THERAPY NON-RESPONDER 165 0.0037
802 INTESTINAL OBSTRUCTION 138 0.0037
803 RETCHING 78 0.0037
804 FEELING HOT 224 0.0037
805 PRODUCT DOSE OMISSION IN ERROR 103 0.0036
806 PRODUCT USE IN UNAPPROVED INDICATION 901 0.0036
807 BLOOD TEST ABNORMAL 51 0.0036
808 GENERALISED TONIC-CLONIC SEIZURE 60 0.0036
809 BURNING SENSATION 254 0.0036
810 INFLUENZA 403 0.0036
811 DRUG PRESCRIBING ERROR 69 0.0036
812 EYE DISORDER 118 0.0036
813 FEBRILE NEUTROPENIA 238 0.0036
814 PELVIC PAIN 65 0.0036
815 HOSPITALISATION 547 0.0036
816 ABNORMAL BEHAVIOUR 141 0.0036
817 THERAPEUTIC RESPONSE DECREASED 215 0.0035
818 SPINAL FRACTURE 71 0.0035
819 SNEEZING 79 0.0035
820 MOVEMENT DISORDER 113 0.0035
821 PANCREATITIS ACUTE 79 0.0035
822 HEPATIC FUNCTION ABNORMAL 131 0.0035
823 LYMPHOCYTE COUNT DECREASED 62 0.0035
824 EMOTIONAL DISTRESS 424 0.0035
825 GASTROINTESTINAL DISORDER 313 0.0035
826 DRUG DISPENSING ERROR 53 0.0035
827 INTENTIONAL PRODUCT MISUSE 301 0.0034
828 OCULAR HYPERAEMIA 163 0.0034
829 MUSCULOSKELETAL STIFFNESS 299 0.0034
830 ABASIA 84 0.0034
831 EXPOSURE VIA SKIN CONTACT 88 0.0034
832 HERPES ZOSTER 195 0.0034
833 SWELLING 317 0.0034
834 ACTIVITIES OF DAILY LIVING IMPAIRED 67 0.0034
835 IMPAIRED HEALING 111 0.0034
836 SINUSITIS 345 0.0034
837 BLOOD GLUCOSE ABNORMAL 62 0.0034
838 IMMUNODEFICIENCY 50 0.0034
839 PYREXIA 1155 0.0033
840 HIP ARTHROPLASTY 51 0.0033
841 RASH GENERALISED 86 0.0033
842 ACCIDENTAL OVERDOSE 121 0.0033
843 LYMPHOMA 51 0.0033
844 STOMATITIS 200 0.0033
845 JOINT SWELLING 396 0.0033
846 ERYTHEMA 674 0.0033
847 NERVOUSNESS 171 0.0033
848 CARDIAC ARREST 269 0.0033
849 MUSCULOSKELETAL DISORDER 62 0.0033
850 EOSINOPHILIA 57 0.0032
851 PRODUCT AVAILABILITY ISSUE 74 0.0032
852 DRUG EFFECT DECREASED 175 0.0032
853 BLOOD GLUCOSE INCREASED 609 0.0032
854 DEATH 2775 0.0032
855 URTICARIA 538 0.0032
856 DISEASE PROGRESSION 378 0.0032
857 COLITIS 121 0.0032
858 RESPIRATORY DISORDER 95 0.0032
859 PAIN 1950 0.0032
860 PRODUCT PHYSICAL ISSUE 64 0.0032
861 INFECTION 458 0.0032
862 NASOPHARYNGITIS 581 0.0031
863 TRANSAMINASES INCREASED 70 0.0031
864 UNEVALUABLE EVENT 237 0.0031
865 GLOSSODYNIA 70 0.0031
866 VIRAL INFECTION 104 0.0031
867 ANGIOEDEMA 137 0.0031
868 NAUSEA 2451 0.0031
869 ACCIDENTAL EXPOSURE TO PRODUCT 319 0.0031
870 LOWER LIMB FRACTURE 59 0.0031
871 TREATMENT NONCOMPLIANCE 168 0.0031
872 SKIN FISSURES 60 0.0031
873 HEMIPARESIS 52 0.0031
874 LACTIC ACIDOSIS 99 0.0031
875 PRESCRIBED OVERDOSE 59 0.0030
876 PRODUCT DOSE OMISSION 199 0.0030
877 HYPERGLYCAEMIA 111 0.0030
878 RESPIRATORY DISTRESS 84 0.0030
879 BLOOD GLUCOSE DECREASED 146 0.0030
880 PRODUCT DOSE OMISSION ISSUE 892 0.0030
881 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 52 0.0030
882 ORAL HERPES 59 0.0030
883 CANDIDA INFECTION 51 0.0030
884 MOUTH ULCERATION 63 0.0030
885 DIABETES MELLITUS 226 0.0030
886 FRACTURE 56 0.0030
887 DRUG EXPOSURE DURING PREGNANCY 100 0.0029
888 METABOLIC ACIDOSIS 94 0.0029
889 LIVER FUNCTION TEST INCREASED 63 0.0029
890 DISCOMFORT 179 0.0029
891 MIGRAINE 280 0.0029
892 C-REACTIVE PROTEIN INCREASED 106 0.0029
893 DRUG-INDUCED LIVER INJURY 91 0.0029
894 VOMITING 1361 0.0029
895 EAR INFECTION 77 0.0029
896 DRUG EFFECT INCOMPLETE 105 0.0029
897 INCREASED APPETITE 55 0.0029
898 CHOLESTASIS 55 0.0029
899 NEUTROPENIA 389 0.0029
900 INFLAMMATION 147 0.0028
901 GASTROENTERITIS VIRAL 51 0.0028
902 LIVER DISORDER 124 0.0028
903 NEUTROPHIL COUNT DECREASED 113 0.0028
904 EYE PRURITUS 93 0.0028
905 UPPER LIMB FRACTURE 55 0.0028
906 SEIZURE 318 0.0028
907 CONJUNCTIVITIS 51 0.0027
908 HEPATITIS 70 0.0027
909 LIVER INJURY 67 0.0027
910 INTENTIONAL DRUG MISUSE 57 0.0027
911 SUICIDE ATTEMPT 165 0.0027
912 WITHDRAWAL SYNDROME 114 0.0027
913 PAIN OF SKIN 72 0.0027
914 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
915 SEPTIC SHOCK 114 0.0026
916 STEVENS-JOHNSON SYNDROME 58 0.0026
917 DRUG INTOLERANCE 252 0.0026
918 KIDNEY INFECTION 51 0.0026
919 PANCREATITIS 137 0.0026
920 FUNGAL INFECTION 85 0.0025
921 INTERSTITIAL LUNG DISEASE 123 0.0025
922 GASTRIC DISORDER 87 0.0025
923 DERMATITIS ATOPIC 133 0.0025
924 SHOCK 58 0.0025
925 LEUKOPENIA 126 0.0025
926 FEMUR FRACTURE 78 0.0025
927 MALIGNANT NEOPLASM PROGRESSION 252 0.0025
928 NEOPLASM MALIGNANT 164 0.0025
929 ILLNESS 252 0.0024
930 INJURY 171 0.0024
931 FIBROMYALGIA 59 0.0024
932 HEPATIC ENZYME INCREASED 165 0.0024
933 TOOTH LOSS 50 0.0024
934 BLADDER CANCER 142 0.0024
935 INFLUENZA LIKE ILLNESS 198 0.0024
936 CARDIOVASCULAR DISORDER 61 0.0024
937 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 56 0.0024
938 RASH MACULO-PAPULAR 53 0.0024
939 TARDIVE DYSKINESIA 67 0.0024
940 PRODUCT COMPLAINT 60 0.0024
941 BONE DENSITY DECREASED 74 0.0024
942 COLITIS ULCERATIVE 105 0.0023
943 SKIN BURNING SENSATION 168 0.0023
944 PRODUCT QUALITY ISSUE 318 0.0023
945 LUNG NEOPLASM MALIGNANT 96 0.0023
946 PSORIATIC ARTHROPATHY 94 0.0023
947 PSORIASIS 299 0.0023
948 OSTEONECROSIS 75 0.0023
949 PROCEDURAL PAIN 63 0.0023
950 ILL-DEFINED DISORDER 136 0.0022
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 65 0.0022
952 SEDATION 58 0.0022
953 OVERDOSE 475 0.0022
954 DRUG DOSE OMISSION 363 0.0022
955 HEPATIC FAILURE 65 0.0022
956 OSTEONECROSIS OF JAW 53 0.0021
957 NEOPLASM PROGRESSION 74 0.0021
958 NO ADVERSE EVENT 382 0.0021
959 DRUG RESISTANCE 54 0.0021
960 INFUSION RELATED REACTION 136 0.0020
961 CONVULSION 117 0.0020
962 MULTIPLE ORGAN DYSFUNCTION SYNDROME 57 0.0020
963 DEVICE ISSUE 179 0.0020
964 RESPIRATORY ARREST 54 0.0020
965 TOXICITY TO VARIOUS AGENTS 312 0.0018
966 CRYING 67 0.0018
967 DRUG ABUSE 133 0.0016
968 DEVICE DISLOCATION 68 0.0016
969 EXTRA DOSE ADMINISTERED 62 0.0015
970 ABORTION SPONTANEOUS 61 0.0015
971 ANAPHYLACTIC REACTION 84 0.0015
972 DRUG WITHDRAWAL SYNDROME 125 0.0014
973 INJECTION SITE HAEMORRHAGE 109 0.0014
974 PRODUCT STORAGE ERROR 117 0.0013
975 TREATMENT FAILURE 105 0.0013
976 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 59 0.0013
977 MULTIPLE SCLEROSIS 60 0.0013
978 INTENTIONAL OVERDOSE 80 0.0012
979 INJECTION SITE SWELLING 95 0.0012
980 RHEUMATOID ARTHRITIS 137 0.0012
981 INJECTION SITE PRURITUS 76 0.0011
982 INJECTION SITE PAIN 336 0.0011
983 RENAL CANCER 52 0.0011
984 INJECTION SITE BRUISING 86 0.0011
985 INJECTION SITE ERYTHEMA 126 0.0010
986 DEVICE MALFUNCTION 71 0.0010
987 BREAST CANCER 85 0.0009
988 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
989 DRUG DEPENDENCE 72 0.0004